MedTrace Logo

Heat-sensitive Moxibustion Self-administration in Patients in the Community With Primary Hypertension: Protocol for a Multi-center, Pragmatic, Non-randomized Trial

NCT04381520 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 767

Last updated 2021-04-05

No results posted yet for this study

Summary

Heat-sensitive moxibustion is considered to be effective for primary hypertension in hospital setting. This study aims to investigate whether heat-sensitive moxibustion self-administration is effective for lowering blood pressure and improving quality of life for patients with primary hypertension in community setting using a multicenter, prospective, non-randomized study design

Conditions

  • Primary Hypertension

Interventions

OTHER

Heat-sensitive moxibustion plus antihypertensive drugs

In this arm, patients will administer heat-sensitive moxibustion by themselves or by the help of their family after professional training. Patients will maintain their original antihypertensive drugs. The periods of treatment and follow-up will be one year.

DRUG

Antihypertensive drugs

In this arm, patients will maintain their original antihypertensive drugs. The periods of treatment and follow-up will be one year.

Sponsors & Collaborators

  • Nangang community healthcare center (Nanchang city, Jiangxi province, China)

    collaborator UNKNOWN

  • Honggutan community healthcare center (Nanchang city, Jiangxi province, China)

    collaborator UNKNOWN

  • Shengmi community healthcare center (Nanchang city, Jiangxi province, China)

    collaborator UNKNOWN

  • Gaofu town community healthcare center (Fu Zhou city, Jiangxi province, China)

    collaborator UNKNOWN

  • Jiangxi University of Traditional Chinese Medicine

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-20
Primary Completion
2021-06-30
Completion
2021-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04381520 on ClinicalTrials.gov